0001209191-16-104904.txt : 20160302
0001209191-16-104904.hdr.sgml : 20160302
20160302200446
ACCESSION NUMBER: 0001209191-16-104904
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160218
FILED AS OF DATE: 20160302
DATE AS OF CHANGE: 20160302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIVATION, INC.
CENTRAL INDEX KEY: 0001011835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133863260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-543-3470
MAIL ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: ORION ACQUISITION CORP II
DATE OF NAME CHANGE: 19960408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powell Andrew Kenneth William
CENTRAL INDEX KEY: 0001304113
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32836
FILM NUMBER: 161479178
MAIL ADDRESS:
STREET 1: C/O COLLAGENEX PHARMACEUTICALS, INC.
STREET 2: 41 UNIVERSITY DRIVE
CITY: NEWTOWN
STATE: PA
ZIP: 18940
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-02-18
0
0001011835
MEDIVATION, INC.
MDVN
0001304113
Powell Andrew Kenneth William
C/O MEDIVATION, INC.
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO
CA
94105
0
1
0
0
SVP, General Counsel & Crp Sec
Common Stock
2016-02-18
4
A
0
9300
0.00
A
38250
D
Stock Option (Right to Buy)
35.77
2016-02-29
4
A
0
38530
0.00
A
2026-02-28
Common Stock
38530
38530
D
Represents the grant of restricted stock units that vest 1/3 on each of March 4, 2017, March 4, 2018 and March 4, 2019.
The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) shall vest on February 28, 2017, and the remaining shares will vest monthly over the three years thereafter.
/s/ Dominic Piscitelli, Attorney-in-fact
2016-03-02